DK167925B1 - 9-substitueret guanin-monohydrat, fremgangsmaade til fremstilling heraf, farmaceutisk praeparat, monohydrat til brug som terapeutisk aktivt middel, monohydrat til brug til behandling af virusinfektioner og anvendelse af et monohydrat til brug ved fremstilling af et medikament - Google Patents

9-substitueret guanin-monohydrat, fremgangsmaade til fremstilling heraf, farmaceutisk praeparat, monohydrat til brug som terapeutisk aktivt middel, monohydrat til brug til behandling af virusinfektioner og anvendelse af et monohydrat til brug ved fremstilling af et medikament Download PDF

Info

Publication number
DK167925B1
DK167925B1 DK356686A DK356686A DK167925B1 DK 167925 B1 DK167925 B1 DK 167925B1 DK 356686 A DK356686 A DK 356686A DK 356686 A DK356686 A DK 356686A DK 167925 B1 DK167925 B1 DK 167925B1
Authority
DK
Denmark
Prior art keywords
monohydrate
compound
treatment
virusin
formula
Prior art date
Application number
DK356686A
Other languages
Danish (da)
English (en)
Other versions
DK356686A (da
DK356686D0 (da
Inventor
Michael Raymond Harnden
Richard Lewis Jarvest
Graham Richard Geen
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858519011A external-priority patent/GB8519011D0/en
Priority claimed from GB858530491A external-priority patent/GB8530491D0/en
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of DK356686D0 publication Critical patent/DK356686D0/da
Publication of DK356686A publication Critical patent/DK356686A/da
Application granted granted Critical
Publication of DK167925B1 publication Critical patent/DK167925B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK356686A 1985-07-27 1986-07-25 9-substitueret guanin-monohydrat, fremgangsmaade til fremstilling heraf, farmaceutisk praeparat, monohydrat til brug som terapeutisk aktivt middel, monohydrat til brug til behandling af virusinfektioner og anvendelse af et monohydrat til brug ved fremstilling af et medikament DK167925B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8519011 1985-07-27
GB858519011A GB8519011D0 (en) 1985-07-27 1985-07-27 Chemical compound
GB858530491A GB8530491D0 (en) 1985-12-11 1985-12-11 Chemical compound
GB8530491 1985-12-11

Publications (3)

Publication Number Publication Date
DK356686D0 DK356686D0 (da) 1986-07-25
DK356686A DK356686A (da) 1987-01-28
DK167925B1 true DK167925B1 (da) 1994-01-03

Family

ID=26289562

Family Applications (1)

Application Number Title Priority Date Filing Date
DK356686A DK167925B1 (da) 1985-07-27 1986-07-25 9-substitueret guanin-monohydrat, fremgangsmaade til fremstilling heraf, farmaceutisk praeparat, monohydrat til brug som terapeutisk aktivt middel, monohydrat til brug til behandling af virusinfektioner og anvendelse af et monohydrat til brug ved fremstilling af et medikament

Country Status (13)

Country Link
US (1) US4942166A (de)
EP (1) EP0216459B1 (de)
JP (1) JPH0670057B2 (de)
AU (1) AU596366B2 (de)
CA (1) CA1262132A (de)
DE (1) DE3671227D1 (de)
DK (1) DK167925B1 (de)
ES (1) ES2000759A6 (de)
GR (1) GR861963B (de)
IE (1) IE58639B1 (de)
MX (1) MX165149B (de)
NZ (1) NZ216978A (de)
PT (1) PT83073B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0141927B1 (de) * 1983-08-18 1991-10-30 Beecham Group Plc Antivirale Guanin-Derivate
IL73682A (en) * 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
US4966895A (en) * 1989-02-02 1990-10-30 Merck & Co. Inc. Cyclic monophosphates of purine and pyrimidine acyclonucleosides as anti-retroviral agents
GB8904855D0 (en) * 1989-03-03 1989-04-12 Beecham Group Plc Pharmaceutical treatment
US6207650B1 (en) * 1989-05-15 2001-03-27 Bristol-Myers Squibb Company Antiviral, highly water soluble, stable, crystalline salts of 2′, 3′-dideoxyinosine, 2′, 3′-dideoxy-2′, 3′-didehydrothymidine and 2′, 3′-dideoxy-2′-fluoroinosine
GB8922076D0 (en) * 1989-09-28 1989-11-15 Beecham Group Plc Novel process
US6469015B1 (en) 1990-01-26 2002-10-22 Novartis International Pharmaceutical Ltd Pharmaceutical formulation
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation
US5674869A (en) * 1990-07-07 1997-10-07 Beecham Group Plc Pharmaceutical treatment
GB9015051D0 (en) * 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment
US5670506A (en) * 1993-04-05 1997-09-23 Cell Therapeutics, Inc. Halogen, isothiocyanate or azide substituted xanthines
US6124304A (en) * 1993-10-05 2000-09-26 Smithkline Beecham Plc Penciclovir for the treatment of zoster associated pain
GB9326177D0 (en) * 1993-12-22 1994-02-23 Smithkline Beecham Plc Pharmaceuticals
US6683084B1 (en) 1993-11-12 2004-01-27 Novartis International Pharmaceutical Ltd. Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
GB9323403D0 (en) * 1993-11-12 1994-01-05 Smithkline Beecham Plc Pharmaceuticals
GB9323404D0 (en) * 1993-11-12 1994-01-05 Smithkline Beecham Plc Pharmaceuticals
GB9504497D0 (en) * 1995-03-07 1995-04-26 Smithkline Beecham Plc Pharmaceuticals
ES2138535B1 (es) * 1996-07-20 2000-11-16 Smithkline Beecham Plc Procedimiento para la preparacion de los compuestos antivirales penciclovir y famciclovir.
GB9615276D0 (en) * 1996-07-20 1996-09-04 Smithkline Beecham Plc Pharmaceuticals
GB9615253D0 (en) * 1996-07-20 1996-09-04 Smithkline Beecham Plc Pharmaceuticals
US6824793B1 (en) 1998-06-01 2004-11-30 Chiron Corporation Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants
US6107303A (en) * 1999-03-15 2000-08-22 Demarco; Charlene C. Treatment of Epstein Barr infection
WO2004018470A2 (en) * 2002-08-26 2004-03-04 Teva Pharmaceutical Industries Ltd. Crystalline solid famciclovir forms i, ii, iii and preparation thereof
AU2006230269A1 (en) 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application
CN110627793B (zh) * 2019-09-10 2020-08-28 天津理工大学 一种喷昔洛韦与3,5-二羟基苯甲酸共晶及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU577303B2 (en) * 1983-08-18 1988-09-22 Novartis International Pharmaceutical Ltd 9-substituted-2-amino purines
EP0141927B1 (de) 1983-08-18 1991-10-30 Beecham Group Plc Antivirale Guanin-Derivate
IL73682A (en) * 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
EP0152316B1 (de) * 1984-01-26 1989-07-26 Merck & Co. Inc. Substituierte Butylguanine und ihre Verwendung in antiviralen Zusammensetzungen
US4642346A (en) * 1985-06-24 1987-02-10 Syntex (U.S.A.) Inc. Anhydrous crystalline 9-(1,3-dihydroxy-2-propoxymethyl)guanine

Also Published As

Publication number Publication date
MX165149B (es) 1992-10-28
US4942166A (en) 1990-07-17
NZ216978A (en) 1990-01-29
PT83073A (en) 1986-08-01
PT83073B (pt) 1989-02-28
DK356686A (da) 1987-01-28
EP0216459B1 (de) 1990-05-16
AU6055786A (en) 1987-01-29
GR861963B (en) 1986-11-26
JPH0670057B2 (ja) 1994-09-07
EP0216459A1 (de) 1987-04-01
ES2000759A6 (es) 1988-03-16
DK356686D0 (da) 1986-07-25
JPS6236381A (ja) 1987-02-17
CA1262132A (en) 1989-10-03
DE3671227D1 (de) 1990-06-21
IE861984L (en) 1987-01-27
AU596366B2 (en) 1990-05-03
IE58639B1 (en) 1993-10-20

Similar Documents

Publication Publication Date Title
DK167925B1 (da) 9-substitueret guanin-monohydrat, fremgangsmaade til fremstilling heraf, farmaceutisk praeparat, monohydrat til brug som terapeutisk aktivt middel, monohydrat til brug til behandling af virusinfektioner og anvendelse af et monohydrat til brug ved fremstilling af et medikament
CA1108622A (en) Metronidazole phosphate and salts
KR100211479B1 (ko) 3-[2-(디메틸아미노)에틸]-n-메틸-1h-인돌-5-메탄술폰아미드의 비강 투여 제제
JP2003530321A (ja) Ｎ−［４−［２−（２−アミノ−４，７−ジヒドロ−４−オキソ−３Ｈ−ピロロ［２，３−ｄ］ピリミジン−５−イル）エチル］ベンゾイル］−Ｌ−グルタミン酸の新規結晶形およびその製造方法
SE452322B (sv) Kristallina 1,1-dioxopenicillanoyloximetyl-6-(d-alfa-amino-alfa-fenylacetamido) penicillanat-p-toluensulfonat-hydrat och farmaceutiska kompositioner derav
DK169657B1 (da) Anvendelse af visse uracilnucleosider til fremstilling af et lægemiddel mod adenovirusinfektioner samt oftalmiske præparater indeholdende sådanne uracilnucleosider
US5190947A (en) Codeine salt of a substituted carboxylic acid, its use and pharmaceutical compositions thereof
SA01220313A (ar) مركبات 10 - أمينو ألفاتيل- ثاني بنز [ب، و] أكسبين ذات فعالية مضادة للانحلال العصبي0.
EP0143658B1 (de) Cephalosporinderivate
KR20040079936A (ko) 염기성 아미노산 ｉｉ를 함유하는 ｏ-아세틸살리실산의안정한 염
WO2016078543A1 (zh) 一种盐酸洛氟普啶多晶型物及其制备方法
HU187644B (en) Process for preparing 2-amino-3-/halogen-benzoyl/-methyl-phenylacetic acid, esters and salts thereof
EP0058079B1 (de) 4-(1-Imidazolylmethyl)-zimtsäure-hydrochlorid-monohydrat, Verfahren zu seiner Herstellung sowie dieses enthaltende pharmazeutische Zusammensetzungen
HU210876A9 (en) Arginine derivatives
GB2074858A (en) Compositions containing 3-deazaaden-osine
EP0055593B1 (de) Präparate, die E-Prostaglandine enthalten
SE452323B (sv) Kristallint 1,1-dioxopenicillanoyloximetyl-6-(d-alfa-amino-alfa-fenylacetamido) penicillanat-2-naftensulfonat och farmaceutiska kompositioner derav
US3253990A (en) N-methyl glucammonium salicylate and uses therefor
EP2979695B1 (de) Therapeutisches mittel gegen augenerkrankungen
US4024259A (en) 3-Anilino-2,4-diazabicyclo[3.2.1]octenes
JPH032183A (ja) ビスベンジルイソキノリン誘導体
HU197985B (en) Method for producing antibacterial lyophilized preparation
AU2004238708A1 (en) Crystal of benzimidazole derivative and process for producing the same
JPS6056974A (ja) 環式ジチオジアセトアミドおよびその製造方法並びに薬剤
IE44093B1 (en) New salts of the dimethylaminoethyl ester of p-chlorophenoxy acetic acid

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired